About Bioassay
Bioassay is a Healthcare company based in Heidelberg (Germany) founded in 2002, and was acquired by Reaction Biology in December 2022. Biological assays for pharmaceutical and chemical products are specialized in. The company has 53 employees. Its chief executive, as recorded, is Sven Michael Cords. Bioassay offers products and services including BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing. Its focus areas include Biopharma Outsourcing, Consulting, Drug Discovery and Preclinical and Life Sciences. Its legal entity is Bioassay GmbH.
Company details
Bioassay GmbH was established in 2002 in Heidelberg, Germany, within the biotechnology sector. Biological assays are developed and performed for quality control and product development in pharmaceuticals and chemicals. Emphasis is placed on areas including BioPharma Potency, Efficacy, Safety, and Safety assessments for Chemicals and Cosmetics. Operations adhere to GMP and GLP guidelines, with ISO certification maintained.
- Headquarters Heidelberg, Germany
- Employees 53
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioassay-online.de
- Social LinkedIn
- Acquired by Reaction Biology (Dec 2022)
- Legal Name Bioassay Gmbh
- Investors
- Employee Count53
- Acquired byReaction Biology
(Dec 2022)
Products & Services of Bioassay
Bioassay offers a comprehensive portfolio of products and services, including BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing.
Develop and validate potency assays for biologics under GMP guidelines.
Conduct efficacy and safety studies for biosimilars and APIs.
Perform qualitative and quantitative analysis using HPLC equipment.
Provide toxicity and sensitization studies for compound selection.
Offer GMP potency testing for animal biologics and products.
Investors in Bioassay
Bioassay has secured backing from 1 investor. Prominent investors backing the company include Reaction Biology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling | 2001 | reactionbiology.com | United States |
Investor details for Bioassay
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bioassay
2 people are tracked at Bioassay (2 in leadership); the tracked headcount is 53.
| Name | Role | Group |
|---|---|---|
Sven Michael Cords | Co-CEO | Leadership |
Axel Hohenstein | Co-CEO | Leadership |
Complete people profiles for Bioassay
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bioassay
2 dated milestones of Bioassay across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Bioassay is founded.
- Exit Acquired by Reaction Biology.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioassay
Complete news archive for Bioassay
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioassay
Bioassay was founded in 2002.
Bioassay is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
Sven Michael Cords is the CEO of Bioassay, as recorded in our data.
Bioassay has 53 employees.
Bioassay GmbH was established in 2002 in Heidelberg, Germany, within the biotechnology sector. Biological assays are developed and performed for quality control and product development in pharmaceuticals and chemicals. Emphasis is placed on areas including BioPharma Potency, Efficacy, Safety, and Safety assessments for Chemicals and Cosmetics. Operations adhere to GMP and GLP guidelines, with ISO certification maintained.
Bioassay offers BioPharma Potency Assays, BioPharma Safety Assessments, Physico-Chemical Analysis, GLP Services, and Veterinary Product Testing.
Bioassay has 1 investor. Key investors include Reaction Biology.
Bioassay operates through Bioassay Gmbh.
Yes. Bioassay was acquired by Reaction Biology in December 2022.